InvestorsHub Logo
Followers 74
Posts 15848
Boards Moderated 0
Alias Born 04/26/2010

Re: ziploc_1 post# 26710

Friday, 04/18/2014 6:15:44 PM

Friday, April 18, 2014 6:15:44 PM

Post# of 428932
I have no fear of ANDA filings and generics stealing our still slim market share, the patent portfolio locks up protection for many, many years - it's the cost of contesting the filings in court that is worrisome. Teva, Par, and every other big generic maker can afford to bleed AMRN to a certain death unless they partner with another BP with deep pockets and 100 lawyers on retainer - dunno if Kowa is up to the task, know nothing about their financials, private company.

Edit: A little OT, but patent trolls are taking their toll on many industries - anyone ever hear of Adam Corolla's podcast? He was the first comedian to move from TV/Radio to podcasting, and hugely successful at it. In a mind boggling decision, someone at the USPTO decided that a podcast, or a serialized event like a playlist, was worthy of a patent (!?!?!). Adam got sued and is fighting back, going to viral funding sites to raise the $1.5M -$3M estimated for court costs. Apple settled for a mere $8M - they probably make that in one minute. It's the sheer existence of such a broad patent that makes the system appear to by run by lunatics!

The Thought Police: To censor and protect. Craig Bruce

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News